Completed PHASE4 INTERVENTIONAL NCT00464217

Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years

PETHEMA-LAM99:Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years

Sponsor: PETHEMA Foundation

Updated 6 times since 2017 Last updated: Jan 3, 2010 Started: Oct 31, 1998 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Acute Myeloblastic Leukaemia and is currently completed. PETHEMA Foundation leads this study, which shows 6 recorded versions since 1998 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PETHEMA Foundation

Data source: PETHEMA Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albacete, Spain , Alicante, Spain , Cadiz, Spain , Cartagena, Spain , Castellon, Spain , Galdakao, Spain , Jaén, Spain , Las Palmas de Gran Canaria, Spain , Lugo, Spain , Madrid, Spain and 9 more locations